In U87 MG human glioblastoma cells, treatment with curcumin led to the upregulation of miR-146a, a negative regulator of NF-κB signaling, while combined curcumin and temozolomide treatment inhibited cell proliferation and induced apoptotic death compared with each alone. Here, NFKB1 is linked to glioblastoma.